These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21204119)

  • 1. A semi-competing risks model for data with interval-censoring and informative observation: an application to the MRC cognitive function and ageing study.
    Barrett JK; Siannis F; Farewell VT
    Stat Med; 2011 Jan; 30(1):1-10. PubMed ID: 21204119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint latent class model for longitudinal data and interval-censored semi-competing events: Application to dementia.
    Rouanet A; Joly P; Dartigues JF; Proust-Lima C; Jacqmin-Gadda H
    Biometrics; 2016 Dec; 72(4):1123-1135. PubMed ID: 27123856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive-multiplicative hazards regression models for interval-censored semi-competing risks data with missing intermediate events.
    Kim J; Kim J; Kim SW
    BMC Med Res Methodol; 2019 Mar; 19(1):49. PubMed ID: 30841923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiparametric competing risks regression under interval censoring using the R package intccr.
    Park J; Bakoyannis G; Yiannoutsos CT
    Comput Methods Programs Biomed; 2019 May; 173():167-176. PubMed ID: 31046992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A semi-Markov model for stroke with piecewise-constant hazards in the presence of left, right and interval censoring.
    Kapetanakis V; Matthews FE; van den Hout A
    Stat Med; 2013 Feb; 32(4):697-713. PubMed ID: 22903796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of censoring in competing risks analysis of the subdistribution hazard.
    Donoghoe MW; Gebski V
    BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression analysis of case K interval-censored failure time data in the presence of informative censoring.
    Wang P; Zhao H; Sun J
    Biometrics; 2016 Dec; 72(4):1103-1112. PubMed ID: 27123560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiparametric copula method for semi-competing risks data subject to interval censoring and left truncation: Application to disability in elderly.
    Sun T; Li Y; Xiao Z; Ding Y; Wang X
    Stat Methods Med Res; 2023 Apr; 32(4):656-670. PubMed ID: 36735020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing semi-competing risks data with missing cause of informative terminal event.
    Zhou R; Zhu H; Bondy M; Ning J
    Stat Med; 2017 Feb; 36(5):738-753. PubMed ID: 27813148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A semi-Markov model for multistate and interval-censored data with multiple terminal events. Application in renal transplantation.
    Foucher Y; Giral M; Soulillou JP; Daures JP
    Stat Med; 2007 Dec; 26(30):5381-93. PubMed ID: 17987670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiparametric regression on cumulative incidence function with interval-censored competing risks data.
    Bakoyannis G; Yu M; Yiannoutsos CT
    Stat Med; 2017 Oct; 36(23):3683-3707. PubMed ID: 28608412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated failure time models for semi-competing risks data in the presence of complex censoring.
    Lee KH; Rondeau V; Haneuse S
    Biometrics; 2017 Dec; 73(4):1401-1412. PubMed ID: 28395116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new framework for semi-Markovian parametric multi-state models with interval censoring.
    Aastveit ME; Cunen C; Hjort NL
    Stat Methods Med Res; 2023 Jun; 32(6):1100-1123. PubMed ID: 37039362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interval-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model?
    Leffondré K; Touraine C; Helmer C; Joly P
    Int J Epidemiol; 2013 Aug; 42(4):1177-86. PubMed ID: 23900486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-Markov models for interval censored transient cognitive states with back transitions and a competing risk.
    Wei S; Kryscio RJ
    Stat Methods Med Res; 2016 Dec; 25(6):2909-2924. PubMed ID: 24821001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiparametric regression of the illness-death model with interval censored disease incidence time: An application to the ACLS data.
    Zhou J; Zhang J; McLain AC; Lu W; Sui X; Hardin JW
    Stat Methods Med Res; 2020 Dec; 29(12):3707-3720. PubMed ID: 32643537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity analysis for informative censoring in parametric survival models.
    Siannis F; Copas J; Lu G
    Biostatistics; 2005 Jan; 6(1):77-91. PubMed ID: 15618529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengthening the interpretability of clinical trial results by assessing the effect of informative censoring on the primary estimand in PRECISION.
    Bao W; Gaffney M; Pressler ML; Fayyad R; Wisemandle W; Beckerman B; Wolski KE; Nissen SE
    Clin Trials; 2020 Oct; 17(5):535-544. PubMed ID: 32643966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint regression analysis for survival data in the presence of two sets of semi-competing risks.
    Peng M; Xiang L
    Biom J; 2019 Nov; 61(6):1402-1416. PubMed ID: 31225925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric association analysis of exchangeable clustered competing risks data.
    Cheng Y; Fine JP; Kosorok MR
    Biometrics; 2009 Jun; 65(2):385-93. PubMed ID: 18549422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.